Work

17-beta estradiol in mitochondrial function and neuroprotection in central and peripheral nervous systems: mechanisms and implications

Year: 2025
Type: article
Abstract: Neurodegenerative diseases, such as Alzheimer's disease (AD) and peripheral neuropathies, are characterized by progressive neuronal damage and dysfunction. Estradiol (E2), a potent estrogen, has been shown to exert neuroprotective effects in both the central nervous system (CNS) and peripheral nervous system (PNS). This thesis investigated the mechanisms underlying E2's neurotrophic and neuroprotective actions in dorsal root ganglion (DRG) neurons and cortical neurons, focusing on mitochondrial function, axonal regeneration, neuroinflammation, and neuronal survival. E2 enhanced mitochondrial respiration and promoted neurite outgrowth in cultured DRG neurons from the PNS through activation of AMP-activated protein kinase (AMPK) and its downstream effectors, including peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and activating transcription factor 3 (ATF3), which are proteins involved in mitochondrial biogenesis and axonal regeneration, respectively. I identified Ca²⁺/calmodulin-dependent protein kinase kinase beta (CaMKKβ) pathway as a key upstream regulator of AMPK activation in DRG neurons. In primary cortical neurons of the CNS, E2 countered amyloid-beta (Aβ)-induced toxicity by improving mitochondrial function and suppressing pro-inflammatory NF-κB signaling, underscoring its potential in mitigating AD-related neuronal loss. Notably, pharmacological inhibition of AMPK using Compound C (CC) abolished E2’s protective effects, confirming AMPK’s central role in mediating E2’s actions in cortical neurons. Collectively, these findings highlight E2’s neurotrophic and neuroprotective effects in both peripheral and central neurons, with AMPK emerging as a critical mediator. Additionally, they underscore the therapeutic potential of targeting mitochondrial health and inflammatory pathways, alongside AMPK, in neurodegenerative disorders. Future research directions include in vivo validation, investigation of sex-specific responses, and development of safer estrogen-based alternatives, such as selective estrogen receptor modulators (SERMs) to fully harness estradiol's multifaceted neuroprotective roles in both CNS and PNS disorders.
Language: English
Subfield: Endocrinology
Open Access status: green
OpenAlex ID: W7137429535
FWCI:
Cites: 479
Cited by:
Related to: 10